NM_000834.5:c.1011-14679T>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000834.5(GRIN2B):​c.1011-14679T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.55 in 151,926 control chromosomes in the GnomAD database, including 23,067 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.55 ( 23067 hom., cov: 31)

Consequence

GRIN2B
NM_000834.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.780

Publications

6 publications found
Variant links:
Genes affected
GRIN2B (HGNC:4586): (glutamate ionotropic receptor NMDA type subunit 2B) This gene encodes a member of the N-methyl-D-aspartate (NMDA) receptor family within the ionotropic glutamate receptor superfamily. The encoded protein is a subunit of the NMDA receptor ion channel which acts as an agonist binding site for glutamate. The NMDA receptors mediate a slow calcium-permeable component of excitatory synaptic transmission in the central nervous system. The NMDA receptors are heterotetramers of seven genetically encoded, differentially expressed subunits including NR1 (GRIN1), NR2 (GRIN2A, GRIN2B, GRIN2C, or GRIN2D) and NR3 (GRIN3A or GRIN3B). The early expression of this gene in development suggests a role in brain development, circuit formation, synaptic plasticity, and cellular migration and differentiation. Naturally occurring mutations within this gene are associated with neurodevelopmental disorders including autism spectrum disorder, attention deficit hyperactivity disorder, epilepsy, and schizophrenia. [provided by RefSeq, Aug 2017]
GRIN2B Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
  • developmental and epileptic encephalopathy, 27
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • intellectual disability, autosomal dominant 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.646 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRIN2BNM_000834.5 linkc.1011-14679T>G intron_variant Intron 4 of 13 ENST00000609686.4 NP_000825.2 Q13224A0A8D9PHB2
GRIN2BNM_001413992.1 linkc.1011-14679T>G intron_variant Intron 5 of 14 NP_001400921.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRIN2BENST00000609686.4 linkc.1011-14679T>G intron_variant Intron 4 of 13 1 NM_000834.5 ENSP00000477455.1 Q13224
GRIN2BENST00000630791.3 linkc.1011-14679T>G intron_variant Intron 5 of 14 5 ENSP00000486677.3 A0A0D9SFK0
GRIN2BENST00000714048.1 linkn.1011-14679T>G intron_variant Intron 4 of 12 ENSP00000519339.1

Frequencies

GnomAD3 genomes
AF:
0.550
AC:
83453
AN:
151808
Hom.:
23055
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.583
Gnomad AMI
AF:
0.645
Gnomad AMR
AF:
0.536
Gnomad ASJ
AF:
0.663
Gnomad EAS
AF:
0.664
Gnomad SAS
AF:
0.496
Gnomad FIN
AF:
0.516
Gnomad MID
AF:
0.544
Gnomad NFE
AF:
0.525
Gnomad OTH
AF:
0.583
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.550
AC:
83490
AN:
151926
Hom.:
23067
Cov.:
31
AF XY:
0.549
AC XY:
40768
AN XY:
74256
show subpopulations
African (AFR)
AF:
0.583
AC:
24140
AN:
41394
American (AMR)
AF:
0.535
AC:
8164
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.663
AC:
2299
AN:
3468
East Asian (EAS)
AF:
0.664
AC:
3432
AN:
5168
South Asian (SAS)
AF:
0.495
AC:
2377
AN:
4806
European-Finnish (FIN)
AF:
0.516
AC:
5442
AN:
10540
Middle Eastern (MID)
AF:
0.534
AC:
157
AN:
294
European-Non Finnish (NFE)
AF:
0.525
AC:
35663
AN:
67966
Other (OTH)
AF:
0.583
AC:
1228
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1909
3817
5726
7634
9543
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
724
1448
2172
2896
3620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.531
Hom.:
27719
Bravo
AF:
0.553
Asia WGS
AF:
0.574
AC:
1993
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
6.0
DANN
Benign
0.82
PhyloP100
0.78
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7972662; hg19: chr12-13843472; API